Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2B | Q13224 | 4/20 | 0.74 |
| ▸ | MEN1 | O00255 | 2/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.74 |
| ▸ | RAB9A | P51151 | 1/20 | 0.74 |
| ▸ | ACHE | P22303 | 6/20 | 0.67 |
| ▸ | BACE1 | P56817 | 6/20 | 0.67 |
| ▸ | BCHE | P06276 | 4/20 | 0.67 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.59 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.59 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.57 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.57 |
| ▸ | FYN | P06241 | 1/20 | 0.56 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2550113 | 0.98 | MEN1 (0.78) | GRIN2BMEN1KMT2ARAB9AACHE | |
| Methyl Alcohol SCHEMBL27513196 | 0.94 | GRIN2B (0.67) | GRIN2BMEN1KMT2ARAB9AACHE | |
| SCHEMBL3184557 | 0.94 | GRIN2B (0.67) | GRIN2BMEN1KMT2ARAB9AACHE | |
| Bicarbonate SCHEMBL11118446 | 0.92 | GRIN2B (0.65) | GRIN2BMEN1KMT2ARAB9AACHE | |
| SCHEMBL433970 | 0.91 | GRIN2B (0.69) | GRIN2BMEN1KMT2ARAB9AACHE | |
| SCHEMBL2954218 | 0.91 | GRIN2B (0.69) | GRIN2BMEN1KMT2ARAB9AACHE | |
| SCHEMBL4173336 | 0.91 | GRIN2B (0.69) | GRIN2BMEN1KMT2ARAB9AACHE | |
| SCHEMBL9028836 | 0.90 | GRIN2B (0.62) | GRIN2BMEN1KMT2ARAB9AACHE | |
| SCHEMBL14657362 | 0.90 | GRIN2B (0.62) | GRIN2BMEN1KMT2ARAB9AACHE | |
| SCHEMBL5694934 | 0.90 | GRIN2B (0.62) | GRIN2BMEN1KMT2ARAB9AACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 302 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117447334-A | Method for efficiently synthesizing alpha-amino acetal | 南京工业大学 | 2024-01-26 | — | — | CN | claimed |
| CN-116410098-A | Preparation method for synthesizing alpha-aminoketone compound from fatty aldehyde and secondary amine | 西北工业大学 | 2023-07-11 | — | — | CN | claimed |
| EP-2635551-B1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED N-(BENZYL)CYCLOPROPANAMINES BY IMINE HYDROGENATION | BAYER CROPSCIENCE AG (DE) | 2018-05-02 | — | — | EP | claimed |
| CN-103402970-B | Process for the preparation of substituted n-(benzyl)cyclopropanamines by imine hydrogenation | 拜耳知识产权有限责任公司 | 2017-02-15 | — | — | CN | claimed |
| US-9260378-B2 | Process for the preparation of substituted N-(benzyl)cyclopropanamines by imine hydrogenation | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2016-02-16 | — | — | US | claimed |
| CN-103402970-A | Process for the preparation of substituted n-(benzyl)cyclopropanamines by imine hydrogenation | BAYER IP GMBH | 2013-11-20 | — | — | CN | claimed |
| EP-2635551-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED N-(BENZYL)CYCLOPROPANAMINES BY IMINE HYDROGENATION | Bayer Cropscience AG (DE) | 2013-09-11 | — | — | EP | claimed |
| US-20130217910-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED N-(BENZYL)CYCLOPROPANAMINES BY IMINE HYDROGENATION | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2013-08-22 | — | — | US | claimed |
| WO-2012059585-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED N-(BENZYL)CYCLOPROPANAMINES BY IMINE HYDROGENATION | BAYER CROPSCIENCE AG (DE) | 2012-05-10 | — | — | WO | claimed |
| EP-1501830-B1 | 7-ARYL-3,9-DIAZABICYCLO[3.3.1]NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES | ACTELION PHARMACEUTICALS LTD (CH) | 2011-10-05 | — | — | EP | claimed |
| US-20080214552-A1 | Substituted Pyridazinecarboxamides and Derivatives Thereof | BAYER CROPSCIENCE AG (DE) | 2008-09-04 | — | — | US | claimed |
| CN-1976585-A | Substituted pyridazine carboxamides and derivatives thereof | BAYER CROPSCIENCE AG (DE) | 2007-06-06 | — | — | CN | claimed |
| EP-1763303-A1 | SUBSTITUTED PYRIDAZINE CARBOXAMIDES AND DERIVATIVES THEREOF | Bayer CropScience Aktiengesellschaft (DE) | 2007-03-21 | — | — | EP | claimed |
| WO-2006000333-A1 | SUBSTITUTED PYRIDAZINE CARBOXAMIDES AND DERIVATIVES THEREOF | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2006-01-05 | — | — | WO | claimed |
| US-4550162-A | Process for the manufacture of enol derivatives | CIBA-GEIGY CORPORATION (US) | 1985-10-29 | — | — | US | claimed |
| US-4434287-A | Cephalosporin derivatives | CIBA-GEIGY CORPORATION (US) | 1984-02-28 | — | — | US | claimed |
| US-4319027-A | Process for the manufacture of ceohem enol derivatives | CIBA-GEIGY CORPORATION (US) | 1982-03-09 | — | — | US | claimed |
| US-4293462-A | Process for the manufacture of enol derivatives, and intermediates | CIBA-GEIGY CORPORATION (US) | 1981-10-06 | — | — | US | claimed |
| US-4110533-A | PROCESS FOR THE MANUFACTURE OF ENOL DERIVATIVES | CIBA-GEIGY CORPORATION (US) | 1978-08-29 | — | — | US | claimed |
| EP-4680608-A1 | 2,6-DIHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7-ONE DERIVATIVES AS ANTI-MALARIAL AGENTS | MMV Medicines for Malaria Venture (CH) | 2026-01-21 | — | — | EP | disclosed |
| EP-4635492-A2 | TRYPTAMINES AND METHODS OF TREATING MOOD DISORDERS | Gilgamesh Pharmaceuticals, Inc. (US) | 2025-10-22 | — | — | EP | disclosed |
| EP-4620949-A1 | ACKR3 MODULATORS FOR CARDIOVASCULAR OR ANTIPLATELET THERAPY | Eberhard Karls Universität Tübingen (Medizinische Fakultät) (DE) | 2025-09-24 | — | — | EP | disclosed |
| EP-4551212-A2 | TRYPTAMINES AND METHODS OF TREATING MOOD DISORDERS | Gilgamesh Pharmaceuticals, Inc. (US) | 2025-05-14 | — | — | EP | disclosed |
| US-20250114460-A1 | NOVEL PLK1 DEGRADATION INDUCING COMPOUND | UPPTHERA, INC. (KR) | 2025-04-10 | — | — | US | disclosed |
| EP-4384520-A1 | NOVEL PLK1 DEGRADATION INDUCING COMPOUND | Uppthera, Inc. (KR) | 2024-06-19 | — | — | EP | disclosed |
| CN-118076607-A | Novel PLK1 degradation inducing compounds | 厄普特拉株式会社 | 2024-05-24 | — | — | CN | disclosed |
| WO-2024035757-A2 | TRYPTAMINES AND METHODS OF TREATING MOOD DISORDERS | GILGAMESH PHARMACEUTICALS, INC. (US) | 2024-02-15 | — | — | WO | disclosed |
| CN-117447334-A | Method for efficiently synthesizing alpha-amino acetal | 南京工业大学 | 2024-01-26 | — | — | CN | disclosed |
| CN-116410098-A | Preparation method for synthesizing alpha-aminoketone compound from fatty aldehyde and secondary amine | 西北工业大学 | 2023-07-11 | — | — | CN | disclosed |
| CN-110818576-B | Secondary amine derivative synthesized by rare earth catalysis and preparation method thereof | 温州大学 | 2023-02-24 | — | — | CN | disclosed |
| WO-2023017446-A1 | NOVEL PLK1 DEGRADATION INDUCING COMPOUND | UPPTHERA, INC. (KR) | 2023-02-16 | — | — | WO | disclosed |
| WO-2023017442-A1 | NOVEL PLK1 DEGRADATION INDUCING COMPOUND | UPPTHERA, INC. (KR) | 2023-02-16 | — | — | WO | disclosed |
| CN-110325531-B | Benzenesulfonamides and their use as therapeutic agents | 泽农医药公司 | 2022-05-27 | — | — | CN | disclosed |
| EP-2908642-B1 | METHOD FOR ENHANCING TOLERANCE TO ABIOTIC STRESS IN PLANTS BY USING CARBOXAMIDE OR THIOCARBOXAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2022-02-23 | — | — | EP | disclosed |
| EP-3177612-B1 | OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES | NUEVOLUTION AS (DK) | 2022-02-23 | — | — | EP | disclosed |
| EP-3177612-B1 | OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES | NUEVOLUTION AS (DK) | 2022-02-23 | — | — | EP | disclosed |
| US-11254681-B2 | Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases | NUEVOLUTION A/S (DK) | 2022-02-22 | — | — | US | disclosed |
| CN-108347948-B | Active compound combinations comprising (thio) carboxamide derivatives and fungicidal compounds | 拜耳作物科学股份公司 | 2021-11-05 | — | — | CN | disclosed |
| US-10945432-B2 | Active compound combinations comprising a (thio)carboxamide derivative and a fungicidal compound | BAYER CROPSCIENCE AKTIENGESELLSCHAFT | 2021-03-16 | — | — | US | disclosed |
| US-10945433-B2 | Method for treating coffee rust, citrus black spot, citrus scab and banana black sigatoka diseases | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2021-03-16 | — | — | US | disclosed |
| EP-3367800-B1 | ACTIVE COMPOUND COMBINATIONS COMPRISING A (THIO)CARBOXAMIDE DERIVATIVE AND A FUNGICIDAL COMPOUND | BAYER CROPSCIENCE AG (DE) | 2021-03-10 | — | — | EP | disclosed |
| US-20210054007-A1 | RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | BEIJING TIDE PHARMACEUTICAL CO., LTD. (CN) | 2021-02-25 | — | — | US | disclosed |
| EP-3770148-A1 | RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | Beijing Tide Pharmaceutical Co., Ltd. (CN) | 2021-01-27 | — | — | EP | disclosed |
| US-20200392140-A1 | OPTIONALLY FUSED HETEROCYCLYL- SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES | NUEVOLUTION A/S (DK) | 2020-12-17 | — | — | US | disclosed |
| CN-107635403-B | Methods for treating coffee rust, citrus black spot, citrus scab, and banana black sigatoka disease | 拜耳作物科学股份公司 | 2020-12-04 | — | — | CN | disclosed |
| WO-2020227592-A1 | THIOSEMICARBAZATES AND USES THEREOF | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2020-11-12 | — | — | WO | disclosed |
| WO-2020163401-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. (US) | 2020-08-13 | — | — | WO | disclosed |
| CN-110577498-B | Triazole compound and application thereof in agriculture | 东莞市东阳光农药研发有限公司 | 2020-07-24 | — | — | CN | disclosed |
| US-10683293-B2 | Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases | NUEVOLUTION A/S (DK) | 2020-06-16 | — | — | US | disclosed |
| CN-108689951-B | Triazole compound and application thereof in agriculture | 东莞市东阳光农药研发有限公司 | 2020-05-19 | — | — | CN | disclosed |
| EP-3297439-B1 | METHOD FOR TREATING COFFEE RUST, CITRUS BLACK SPOT, CITRUS SCAB AND BANANA BLACK SIGATOKA DISEASES | BAYER CROPSCIENCE AG (DE) | 2020-03-04 | — | — | EP | disclosed |
| US-20200045965-A1 | METHOD FOR THE CONTROL OF PLANT BACTERIAL DISEASES USING CARBOXAMIDE DERIVATIVES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2020-02-13 | — | — | US | disclosed |
| EP-3606910-A1 | TRIAZOLE COMPOUND AND USE THEREOF IN AGRICULTURE | Dongguan Hec Pesticides R&D Co., Ltd. (CN) | 2020-02-12 | — | — | EP | disclosed |
| CN-107105650-B | Active compound combinations comprising (thio) carboxamide derivatives and one or more fungicidal compounds | 拜耳作物科学股份公司 | 2019-12-20 | — | — | CN | disclosed |
| CN-110577498-A | Triazole compound and application thereof in agriculture | 东莞市东阳光农药研发有限公司 | 2019-12-17 | — | — | CN | disclosed |
| EP-3554239-A1 | METHOD FOR THE CONTROL OF PLANT BACTERIAL DISEASES USING CARBOXAMIDE DERIVATIVES | Bayer CropScience Aktiengesellschaft (DE) | 2019-10-23 | — | — | EP | disclosed |
| EP-2908640-B1 | METHOD OF PLANT GROWTH PROMOTION USING CARBOXAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2019-10-02 | — | — | EP | disclosed |
| US-20190281826-A1 | METHOD FOR TREATING COFFEE RUST, CITRUS BLACK SPOT, CITRUS SCAB AND BANANA BLACK SIGATOKA DISEASES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2019-09-19 | — | — | US | disclosed |
| CN-110072390-A | Use the method for carboxamides derivatives prevention and treatment bacterial diseases of plants | 拜耳作物科学股份公司 | 2019-07-30 | — | — | CN | disclosed |
| US-10349658-B2 | Method for treating coffee rust, citrus black spot, citrus scab and banana black sigatoka diseases | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2019-07-16 | — | — | US | disclosed |
| US-20190159452-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING A (THIO)CARBOXAMIDE DERIVATIVE AND A FUNGICIDAL COMPOUND | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2019-05-30 | — | — | US | disclosed |
| EP-2908643-B1 | ACTIVE COMPOUND COMBINATIONS COMPRISING CARBOXAMIDE DERIVATIVES AND A BIOLOGICAL CONTROL AGENT | BAYER CROPSCIENCE AG (DE) | 2019-03-20 | — | — | EP | disclosed |
| CN-105357967-B | Method for promoting plant growth using carboxamide derivatives | 拜尔农科股份公司 | 2019-02-19 | — | — | CN | disclosed |
| CN-109134297-A | One inter-species di alkylamino group phenol is continuously synthesizing to method | 江苏迪安化工有限公司 | 2019-01-04 | — | — | CN | disclosed |
| CN-104735985-B | Enhance the method for the tolerance in plant to abiotic stress using carboxylic acid amides or thiocarboxamide derivative | 拜尔农科股份公司 | 2018-10-16 | — | — | CN | disclosed |
| WO-2018184579-A1 | TRIAZOLE COMPOUND AND USE THEREOF IN AGRICULTURE | DONGGUAN HEC TECH R&D CO., LTD. (CN) | 2018-10-11 | — | — | WO | disclosed |
| EP-3367800-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING A (THIO)CARBOXAMIDE DERIVATIVE AND A FUNGICIDAL COMPOUND | Bayer CropScience Aktiengesellschaft (DE) | 2018-09-05 | — | — | EP | disclosed |
| CN-108347948-A | Include the active agent combinations of (thio) carboxamide derivative and Fungicidal compounds | 拜耳作物科学股份公司 | 2018-07-31 | — | — | CN | disclosed |
| EP-3057424-B1 | ACTIVE COMPOUND COMBINATIONS COMPRISING A (THIO)CARBOXAMIDE DERIVATIVE AND A FUNGICIDAL COMPOUND | BAYER CROPSCIENCE AG (DE) | 2018-07-04 | — | — | EP | disclosed |
| CN-105658061-B | Active agent combinations comprising (thio) carboxamide derivative and Fungicidal compounds | 拜耳作物科学股份公司 | 2018-06-22 | — | — | CN | disclosed |
| WO-2018109062-A1 | METHOD FOR THE CONTROL OF PLANT BACTERIAL DISEASES USING CARBOXAMIDE DERIVATIVES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-06-21 | — | — | WO | disclosed |
| US-20180153169-A1 | METHOD FOR TREATING COFFEE RUST, CITRUS BLACK SPOT, CITRUS SCAB AND BANANA BLACK SIGATOKA DISEASES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-06-07 | — | — | US | disclosed |
| EP-2635551-B1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED N-(BENZYL)CYCLOPROPANAMINES BY IMINE HYDROGENATION | BAYER CROPSCIENCE AG (DE) | 2018-05-02 | — | — | EP | disclosed |
| EP-2961736-B1 | INHIBITORS OF HISTONE DEMETHYLASES | GILEAD SCIENCES INC (US) | 2018-04-11 | — | — | EP | disclosed |
| EP-3297439-A1 | METHOD FOR TREATING COFFEE RUST, CITRUS BLACK SPOT, CITRUS SCAB AND BANANA BLACK SIGATOKA DISEASES | Bayer CropScience Aktiengesellschaft (DE) | 2018-03-28 | — | — | EP | disclosed |
| CN-107635403-A | For treating coffee rust, citrus black spot, citrus scab and the method for banana secret note leaf spot disease | 拜耳作物科学股份公司 | 2018-01-26 | — | — | CN | disclosed |
| EP-2908641-B1 | METHOD FOR TREATING PLANTS AGAINST FUNGI RESISTANT TO FUNGICIDES USING CARBOXAMIDE OR THIOCARBOXAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2018-01-10 | — | — | EP | disclosed |
| US-20170347651-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING A (THIO)CARBOXAMIDE DERIVATIVE AND FUNGICIDAL COMPOUND(S) | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2017-12-07 | — | — | US | disclosed |
| US-20170342074-A1 | OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES | NUEVOLUTION A/S (DK) | 2017-11-30 | — | — | US | disclosed |
| US-20170342074-A1 | OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES | NUEVOLUTION A/S (DK) | 2017-11-30 | — | — | US | disclosed |
| CN-104869829-B | Reactive compound compound comprising carboxamide derivative and biocontrol agent | 拜尔农科股份公司 | 2017-11-17 | — | — | CN | disclosed |
| CN-105451556-B | Plant is handled to resist the method for the fungi resistant to fungicide using carboxylic acid amides or thiocarboxamide derivative | 拜尔农科股份公司 | 2017-11-14 | — | — | CN | disclosed |
| CN-107337610-A | The synthesis and application of new beta adrenoceptor agonists universal hapten | 南京量子化工科技有限公司 | 2017-11-10 | — | — | CN | disclosed |
| US-9801374-B2 | Active compound combinations comprising carboxamide derivatives | BAYER CROPSCIENCE AG (DE) | 2017-10-31 | — | — | US | disclosed |
| EP-3232782-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING A (THIO)CARBOXAMIDE DERIVATIVE AND FUNGICIDAL COMPOUND(S) | Bayer CropScience Aktiengesellschaft (DE) | 2017-10-25 | — | — | EP | disclosed |
| CN-107105650-A | Active agent combinations comprising (thio) carboxamide derivative and one or more Fungicidal compounds | 拜耳作物科学股份公司 | 2017-08-29 | — | — | CN | disclosed |
| CN-107056621-A | The method for preparing N (isopropyl benzyl of 5 chlorine 2) cyclopropylamine | 拜耳作物科学股份公司 | 2017-08-18 | — | — | CN | disclosed |
| EP-2841413-B1 | PROCESS FOR PREPARING N-(5-CHLORO-2-ISOPROPYLBENZYL)CYCLOPROPANAMINE | BAYER CROPSCIENCE AG (DE) | 2017-07-26 | — | — | EP | disclosed |
| US-9668480-B2 | Method for treating plants against fungi resistant to fungicides using carboxamide or thiocarboxamide derivatives | BAYER CROPSCIENCE AG (DE) | 2017-06-06 | — | — | US | disclosed |
| EP-3170811-A1 | ETHYL PYRIDINE-4-CARBOXYLATE COMPOUND AS INHIBITOR OF HISTONE DEMETHYLASES | Gilead Sciences, Inc. (US) | 2017-05-24 | — | — | EP | disclosed |
| US-9656964-B2 | Method for producing carboxamides | BAYER CROPSCIENCE AG (DE) | 2017-05-23 | — | — | US | disclosed |
| US-9656964-B2 | Method for producing carboxamides | BAYER CROPSCIENCE AG (DE) | 2017-05-23 | — | — | US | disclosed |
| US-9650339-B2 | Inhibitors of histone demethylases | GILEAD SCIENCES, INC. (US) | 2017-05-16 | — | — | US | disclosed |
| WO-2017072166-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING A (THIO)CARBOXAMIDE DERIVATIVE AND A FUNGICIDAL COMPOUND | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2017-05-04 | — | — | WO | disclosed |
| US-20170114029-A1 | TREATMENT OF CHAGAS DISEASE | SYNGENE INTERNATIONAL LIMITED (IN) | 2017-04-27 | — | — | US | disclosed |
| US-9580390-B2 | Indazole compounds as kinase inhibitors and method of treating cancer with same | UNIVERSITY HEALTH NETWORK (CA) | 2017-02-28 | — | — | US | disclosed |
| CN-103402970-B | Process for the preparation of substituted n-(benzyl)cyclopropanamines by imine hydrogenation | 拜耳知识产权有限责任公司 | 2017-02-15 | — | — | CN | disclosed |
| CN-103402970-B | Process for the preparation of substituted n-(benzyl)cyclopropanamines by imine hydrogenation | 拜耳知识产权有限责任公司 | 2017-02-15 | — | — | CN | disclosed |
| CN-103402970-B | Process for the preparation of substituted n-(benzyl)cyclopropanamines by imine hydrogenation | 拜耳知识产权有限责任公司 | 2017-02-15 | — | — | CN | disclosed |
| WO-2016184879-A1 | METHOD FOR TREATING COFFEE RUST, CITRUS BLACK SPOT, CITRUS SCAB AND BANANA BLACK SIGATOKA DISEASES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2016-11-24 | — | — | WO | disclosed |
| US-20160262393-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING A (THIO)CARBOXAMIDE DERIVATIVE AND A FUNGICIDAL COMPOUND | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2016-09-15 | — | — | US | disclosed |
| US-9439426-B2 | Active compound combinations comprising carboxamide derivatives and a biological control agent | BAYER CROPSCIENCE AG (DE) | 2016-09-13 | — | — | US | disclosed |
| US-9440908-B2 | Process for preparing N-(5-chloro-2-isopropylbenzyl)cyclopropanamine | BAYER CROPSCIENCE AG (DE) | 2016-09-13 | — | — | US | disclosed |
| EP-3057424-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING A (THIO)CARBOXAMIDE DERIVATIVE AND A FUNGICIDAL COMPOUND | Bayer CropScience Aktiengesellschaft (DE) | 2016-08-24 | — | — | EP | disclosed |
| US-20160237037-A1 | INHIBITORS OF HISTONE DEMETHYLASES | GILEAD SCIENCES, INC. | 2016-08-18 | — | — | US | disclosed |
| US-9409917-B2 | Heterocyclic amide derivatives as P2X7 receptor antagonists | ACTELION PHARMACEUTICALS LTD. (CH) | 2016-08-09 | — | — | US | disclosed |
| WO-2016096782-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING A (THIO)CARBOXAMIDE DERIVATIVE AND FUNGICIDAL COMPOUND(S) | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2016-06-23 | — | — | WO | disclosed |
| CN-105658061-A | Active compound combinations comprising a (thio)carboxamide derivative and a fungicidal compound | 拜耳作物科学股份公司 | 2016-06-08 | — | — | CN | disclosed |
| CN-105451556-A | Method for treating plants against fungi resistant to fungicides using carboxamide or thiocarboxamide derivatives | BAYER CROPSCIENCE AG | 2016-03-30 | — | — | CN | disclosed |
| CN-105357968-A | Active compound combinations comprising carboxamide derivatives | BAYER CROPSCIENCE AG | 2016-02-24 | — | — | CN | disclosed |
| CN-105357967-A | Method for promoting plant growth using carboxamide derivatives | BAYER CROPSCIENCE AG | 2016-02-24 | — | — | CN | disclosed |
| US-9260378-B2 | Process for the preparation of substituted N-(benzyl)cyclopropanamines by imine hydrogenation | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2016-02-16 | — | — | US | disclosed |
| US-9260378-B2 | Process for the preparation of substituted N-(benzyl)cyclopropanamines by imine hydrogenation | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2016-02-16 | — | — | US | disclosed |
| US-9260378-B2 | Process for the preparation of substituted N-(benzyl)cyclopropanamines by imine hydrogenation | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2016-02-16 | — | — | US | disclosed |
| CN-102812006-B | Novel antimalaria reagent | MMV MEDICINES FOR MALARIA VENTURE (CH) | 2016-01-20 | — | — | CN | disclosed |
| US-20160009655-A1 | METHOD FOR PRODUCING CARBOXAMIDES | BAYER CROPSCIENCE AG (DE) | 2016-01-14 | — | — | US | disclosed |
| EP-2961736-A1 | INHIBITORS OF HISTONE DEMETHYLASES | Epitherapeutics ApS (DK) | 2016-01-06 | — | — | EP | disclosed |
| US-9221801-B2 | Inhibitors of histone demethylases | EPITHERAPEUTICS APS (DK) | 2015-12-29 | — | — | US | disclosed |
| US-9150545-B2 | Carboxamide compounds and their use as calpain inhibitors V | AbbVie Deutschland GmbH & Co. KG (DE) | 2015-10-06 | — | — | US | disclosed |
| US-20150264927-A1 | METHOD FOR TREATING PLANTS AGAINST FUNGI RESISTANT TO FUNGICIDES USING CARBOXAMIDE OR THIOCARBOXAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2015-09-24 | — | — | US | disclosed |
| US-20150264928-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING CARBOXAMIDE DERIVATIVES AND A BIOLOGICAL CONTROL AGENT | BAYER CROPSCIENCE AG (DE) | 2015-09-24 | — | — | US | disclosed |
| US-20150259294-A1 | METHOD OF PLANT GROWTH PROMOTION USING CARBOXAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2015-09-17 | — | — | US | disclosed |
| US-20150250176-A1 | METHOD FOR ENHANCING TOLERANCE TO ABIOTIC STRESS IN PLANTS USING CARBOXAMIDE OR THIOCARBOXAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2015-09-10 | — | — | US | disclosed |
| US-20150245610-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING CARBOXAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2015-09-03 | — | — | US | disclosed |
| EP-2908643-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING CARBOXAMIDE DERIVATIVES AND A BIOLOGICAL CONTROL AGENT | Bayer Cropscience AG (DE) | 2015-08-26 | — | — | EP | disclosed |
| EP-2908642-A1 | METHOD FOR ENHANCING TOLERANCE TO ABIOTIC STRESS IN PLANTS USING CARBOXAMIDE OR THIOCARBOXAMIDE DERIVATIVES | Bayer Cropscience AG (DE) | 2015-08-26 | — | — | EP | disclosed |
| EP-2908639-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING CARBOXAMIDE DERIVATIVES | Bayer Cropscience AG (DE) | 2015-08-26 | — | — | EP | disclosed |
| EP-2908641-A1 | METHOD FOR TREATING PLANTS AGAINST FUNGI RESISTANT TO FUNGICIDES USING CARBOXAMIDE OR THIOCARBOXAMIDE DERIVATIVES | Bayer Cropscience AG (DE) | 2015-08-26 | — | — | EP | disclosed |
| EP-2908640-A1 | METHOD OF PLANT GROWTH PROMOTION USING CARBOXAMIDE DERIVATIVES | Bayer Cropscience AG (DE) | 2015-08-26 | — | — | EP | disclosed |
| CN-104869829-A | Active compound combinations comprising carboxamide derivatives and a biological control agent | BAYER CROPSCIENCE AG | 2015-08-26 | — | — | CN | disclosed |
| EP-2526090-B1 | NEW ANTI-MALARIAL AGENTS | MEDICINES FOR MALARIA VENTURE MMV (CH) | 2015-08-19 | — | — | EP | disclosed |
| WO-2015055707-A9 | ACTIVE COMPOUND COMBINATIONS COMPRISING A (THIO)CARBOXAMIDE DERIVATIVE AND A FUNGICIDAL COMPOUND | BAYER CROPSCIENCE AG (DE) | 2015-07-02 | — | — | WO | disclosed |
| CN-104735985-A | Method for enhancing tolerance to abiotic stress in plants using carboxamide or thiocarboxamide derivatives | BAYER CROPSCIENCE AG | 2015-06-24 | — | — | CN | disclosed |
| US-9024033-B2 | Anti-malarial agents | MMV MEDICINES FOR MALARIA VENTURE (CH) | 2015-05-05 | — | — | US | disclosed |
| WO-2015055707-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING A (THIO)CARBOXAMIDE DERIVATIVE AND A FUNGICIDAL COMPOUND | BAYER CROPSCIENCE AG (DE) | 2015-04-23 | — | — | WO | disclosed |
| US-20150094492-A1 | PROCESS FOR PREPARING N-(5-CHLORO-2-ISOPROPYLBENZYL)CYCLOPROPANAMINE | BAYER CROPSCIENCE AG (DE) | 2015-04-02 | — | — | US | disclosed |
| WO-2015042405-A1 | PH SWITCHABLE REAGENTS AND METHODS FOR THEIR USE | IMPOSSIBLE FOODS INC. (US) | 2015-03-26 | — | — | WO | disclosed |
| US-20150065477-A1 | CARBOXAMIDE COMPOUNDS AND THEIR USE AS CALPAIN INHIBITORS V | AbbVie Deutschland GmbH & Co. KG (DE) | 2015-03-05 | — | — | US | disclosed |
| EP-2841413-A1 | PROCESS FOR PREPARING N-(5-CHLORO-2-ISOPROPYLBENZYL)CYCLOPROPANAMINE | Bayer Cropscience AG (DE) | 2015-03-04 | — | — | EP | disclosed |
| CN-104364247-A | Carboxamide compounds and their use as calpain inhibitors V | ABBVIE DEUTSCHLAND | 2015-02-18 | — | — | CN | disclosed |
| EP-2834230-A1 | CARBOXAMIDE COMPOUNDS AND THEIR USE AS CALPAIN INHIBITORS V | AbbVie Deutschland GmbH & Co KG (DE) | 2015-02-11 | — | — | EP | disclosed |
| US-20150025075-A1 | HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS | ACTELION PHARMACEUTICALS LTD. (CH) | 2015-01-22 | — | — | US | disclosed |
| CN-104245660-A | Process for the preparation of N- (5-chloro-2-isopropylbenzyl) -cyclopropylamine | BAYER CROPSCIENCE AG | 2014-12-24 | — | — | CN | disclosed |
| US-20140371214-A1 | INHIBITORS OF HISTONE DEMETHYLASES | GILEAD SCIENCES, INC. | 2014-12-18 | — | — | US | disclosed |
| EP-2804865-A1 | HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS | Actelion Pharmaceuticals Ltd. (CH) | 2014-11-26 | — | — | EP | disclosed |
| CN-102482256-B | N-substituted cyclic amino derivatives | DAINIPPON SUMITOMO PHARMA CO | 2014-11-26 | — | — | CN | disclosed |
| WO-2014131777-A1 | INHIBITORS OF HISTONE DEMETHYLASES | EPITHERAPEUTICS APS (DK) | 2014-09-04 | — | — | WO | disclosed |
| WO-2014060519-A1 | METHOD FOR ENHANCING TOLERANCE TO ABIOTIC STRESS IN PLANTS USING CARBOXAMIDE OR THIOCARBOXAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2014-04-24 | — | — | WO | disclosed |
| WO-2014060518-A1 | METHOD OF PLANT GROWTH PROMOTION USING CARBOXAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2014-04-24 | — | — | WO | disclosed |
| WO-2014060502-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING CARBOXAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2014-04-24 | — | — | WO | disclosed |
| WO-2014060520-A1 | METHOD FOR TREATING PLANTS AGAINST FUNGI RESISTANT TO FUNGICIDES USING CARBOXAMIDE OR THIOCARBOXAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2014-04-24 | — | — | WO | disclosed |
| WO-2014060521-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING CARBOXAMIDE DERIVATIVES AND A BIOLOGICAL CONTROL AGENT | BAYER CROPSCIENCE AG (DE) | 2014-04-24 | — | — | WO | disclosed |
| CN-101952280-B | Bicyclic heterocyclic derivative | DAINIPPON SUMITOMO PHARMA CO | 2014-04-23 | — | — | CN | disclosed |
| WO-2014056083-A1 | KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH SAME | UNIVERSITY HEALTH NETWORK (CA) | 2014-04-17 | — | — | WO | disclosed |
| US-8658639-B2 | N-substituted-cyclic amino derivative | DAINIPPON SUMITOMO PHARMA CO., LTD (JP) | 2014-02-25 | — | — | US | disclosed |
| US-20140005167-A1 | KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH SAME | UNIVERSITY HEALTH NETWORKS (CA) | 2014-01-02 | — | — | US | disclosed |
| CN-103402970-A | Process for the preparation of substituted n-(benzyl)cyclopropanamines by imine hydrogenation | BAYER IP GMBH | 2013-11-20 | — | — | CN | disclosed |
| CN-103402970-A | Process for the preparation of substituted n-(benzyl)cyclopropanamines by imine hydrogenation | BAYER IP GMBH | 2013-11-20 | — | — | CN | disclosed |
| CN-103402970-A | Process for the preparation of substituted n-(benzyl)cyclopropanamines by imine hydrogenation | BAYER IP GMBH | 2013-11-20 | — | — | CN | disclosed |
| WO-2013160387-A1 | PROCESS FOR PREPARING N-(5-CHLORO-2-ISOPROPYLBENZYL)CYCLOPROPANAMINE | BAYER CROPSCIENCE AG (DE) | 2013-10-31 | — | — | WO | disclosed |
| WO-2013149800-A1 | CARBOXAMIDE COMPOUNDS AND THEIR USE AS CALPAIN INHIBITORS V | AbbVie Deutschland GmbH & Co. KG (DE) | 2013-10-10 | — | — | WO | disclosed |
| EP-2635551-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED N-(BENZYL)CYCLOPROPANAMINES BY IMINE HYDROGENATION | Bayer Cropscience AG (DE) | 2013-09-11 | — | — | EP | disclosed |
| EP-2635551-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED N-(BENZYL)CYCLOPROPANAMINES BY IMINE HYDROGENATION | Bayer Cropscience AG (DE) | 2013-09-11 | — | — | EP | disclosed |
| US-20130217910-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED N-(BENZYL)CYCLOPROPANAMINES BY IMINE HYDROGENATION | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2013-08-22 | — | — | US | disclosed |
| US-20130217910-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED N-(BENZYL)CYCLOPROPANAMINES BY IMINE HYDROGENATION | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2013-08-22 | — | — | US | disclosed |
| WO-2013108227-A1 | HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS | ACTELION PHARMACEUTICALS LTD (CH) | 2013-07-25 | — | — | WO | disclosed |
| US-8420679-B2 | Aminothiazole derivatives and their use as CRF receptor ligands | SANOFI (FR) | 2013-04-16 | — | — | US | disclosed |
| EP-1981866-B8 | N-cyclopropyl-N-benzylamides as fungicides | BAYER IP GMBH (DE) | 2013-04-10 | — | — | EP | disclosed |
| US-20130074216-A1 | TOMATO CATECHOL-O-METHYLTRANSFERASE SEQUENCES AND METHODS OF USE | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2013-03-21 | — | — | US | disclosed |
| US-8389511-B2 | Bicyclic heterocyclic derivative | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2013-03-05 | — | — | US | disclosed |
| EP-1981866-B1 | N-cyclopropyl-N-benzylamides as fungicides | BAYER CROPSCIENCE AG (DE) | 2013-02-27 | — | — | EP | disclosed |
| EP-1992613-B1 | PROCESS FOR PRODUCTION OF 3,4-DISUBSTITUTED PYRROLIDINE DERIVATIVE AND INTERMEDIATE FOR THE PRODUCTION | KYORIN SEIYAKU KK (JP) | 2013-01-30 | — | — | EP | disclosed |
| US-20120295905-A1 | NEW ANTI-MALARIAL AGENTS | MMV MEDICINES FOR MALARIA VENTURE (CH) | 2012-11-22 | — | — | US | disclosed |
| CN-102482256-A | N-substituted cyclic amino derivatives | DAINIPPON SUMITOMO PHARMA CO | 2012-05-30 | — | — | CN | disclosed |
| US-20120122773-A1 | N-SUBSTITUTED-CYCLIC AMINO DERIVATIVE | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2012-05-17 | — | — | US | disclosed |
| WO-2012059585-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED N-(BENZYL)CYCLOPROPANAMINES BY IMINE HYDROGENATION | BAYER CROPSCIENCE AG (DE) | 2012-05-10 | — | — | WO | disclosed |
| WO-2012059585-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED N-(BENZYL)CYCLOPROPANAMINES BY IMINE HYDROGENATION | BAYER CROPSCIENCE AG (DE) | 2012-05-10 | — | — | WO | disclosed |
| EP-2447264-A1 | N-SUBSTITUTED-CYCLIC AMINO DERIVATIVE | Dainippon Sumitomo Pharma Co., Ltd. (JP) | 2012-05-02 | — | — | EP | disclosed |
| US-20120046293-A1 | RENIN INHIBITORS | MERCK FROSST CANADA LTD. (CA) | 2012-02-23 | — | — | US | disclosed |
| US-20120046293-A1 | RENIN INHIBITORS | MERCK FROSST CANADA LTD. (CA) | 2012-02-23 | — | — | US | disclosed |
| US-20120046293-A1 | RENIN INHIBITORS | MERCK FROSST CANADA LTD. (CA) | 2012-02-23 | — | — | US | disclosed |
| US-8063105-B2 | Renin inhibitors | MERCK CANADA INC. (CA) | 2011-11-22 | — | — | US | disclosed |
| US-8063105-B2 | Renin inhibitors | MERCK CANADA INC. (CA) | 2011-11-22 | — | — | US | disclosed |
| US-8063105-B2 | Renin inhibitors | MERCK CANADA INC. (CA) | 2011-11-22 | — | — | US | disclosed |
| EP-1385820-B1 | ANTHRANILIC ACID AMIDES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS ANTIARRHYTHMIA AGENTS, AND PHARMACEUTICAL PREPARATIONS THEREOF | SANOFI AVENTIS DEUTSCHLAND (DE) | 2011-10-12 | — | — | EP | disclosed |
| EP-1501830-B1 | 7-ARYL-3,9-DIAZABICYCLO[3.3.1]NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES | ACTELION PHARMACEUTICALS LTD (CH) | 2011-10-05 | — | — | EP | disclosed |
| US-20110190278-A1 | BICYCLIC HETEROCYCLIC DERIVATIVE | DAINIPPON SUMITOMO PHARMA CO. | 2011-08-04 | — | — | US | disclosed |
| WO-2011086531-A2 | NEW ANTI-MALARIAL AGENTS | MMV MEDICINES FOR MALARIA VENTURE (CH) | 2011-07-21 | — | — | WO | disclosed |
| CN-101146530-B | 3, 4-substituted pyrrolidine derivatives for the treatment of hypertension | NOVARTIS AG | 2011-05-18 | — | — | CN | disclosed |
| EP-1554239-B1 | SULFONYLAMINO-ACETIC ACID DERIVATIVES AND THEIR USE AS OREXIN RECEPTOR ANTAGONISTS | ACTELION PHARMACEUTICALS LTD (CH) | 2011-01-26 | — | — | EP | disclosed |
| CN-101952280-A | Bicyclic heterocyclic derivative | DAINIPPON SUMITOMO PHARMA CO | 2011-01-19 | — | — | CN | disclosed |
| US-20100324091-A1 | Pyrazolone Derivative | KOWA COMPANY, LTD. (JP) | 2010-12-23 | — | — | US | disclosed |
| EP-1863477-B1 | 3,4-SUBSTITUTED PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF HYPERTENSION | NOVARTIS AG (CH) | 2010-11-03 | — | — | EP | disclosed |
| EP-2243779-A1 | BICYCLIC HETEROCYCLIC DERIVATIVE | Dainippon Sumitomo Pharma Co., Ltd. (JP) | 2010-10-27 | — | — | EP | disclosed |
| US-7807709-B2 | Organic compounds | NOVARTIS AG (CH) | 2010-10-05 | — | — | US | disclosed |
| EP-2172458-A1 | PYRAZOLONE DERIVATIVE | Kowa Company, Ltd. (JP) | 2010-04-07 | — | — | EP | disclosed |
| US-20100056497-A1 | AMIDE DERIVATIVE | DAINIPPON SUMITOMO PHARMA CO., LTD (JP) | 2010-03-04 | — | — | US | disclosed |
| EP-2119702-A1 | AMIDE DERIVATIVE | Dainippon Sumitomo Pharma Co., Ltd. (JP) | 2009-11-18 | — | — | EP | disclosed |
| US-20090281103-A1 | Renin Inhibitors | MERCK CANADA INC. (CA) | 2009-11-12 | — | — | US | disclosed |
| US-20090281103-A1 | Renin Inhibitors | MERCK CANADA INC. (CA) | 2009-11-12 | — | — | US | disclosed |
| US-20090281103-A1 | Renin Inhibitors | MERCK CANADA INC. (CA) | 2009-11-12 | — | — | US | disclosed |
| US-7563806-B2 | Substituted cycloalkyl derivatives, process for the manufacture thereof and use thereof as medicament | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-07-21 | — | — | US | disclosed |
| US-20080312242-A1 | 7-ARYL-3, 9-DIAZABICYCLO(3.3.1)NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES | ACTELION PHARMACEUTICALS, LTD. (CH) | 2008-12-18 | — | — | US | disclosed |
| EP-1992613-A1 | PROCESS FOR PRODUCTION OF 3,4-DISUBSTITUTED PYRROLIDINE DERIVATIVE AND INTERMEDIATE FOR THE PRODUCTION | Kyorin Pharmaceutical Co., Ltd. (JP) | 2008-11-19 | — | — | EP | disclosed |
| WO-2008137102-A2 | METHODS OF MODULATING AMYLOID BETA AND COMPOUNDS USEFUL THEREFOR | TORREYPINES THERAPEUTICS, INC. (US) | 2008-11-13 | — | — | WO | disclosed |
| US-7435815-B2 | Sulfonylamino-acetic acid derivatives | ACTELION PHARMACEUTICALS LTD. (CH) | 2008-10-14 | — | — | US | disclosed |
| US-7427613-B2 | 7-aryl-3,9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases | ACTELION PHARMACEUTICALS LTD. (CH) | 2008-09-23 | — | — | US | disclosed |
| US-7423035-B2 | Substituted cycloalkyl derivatives, process for the manufacture thereof and use thereof as medicament | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-09-09 | — | — | US | disclosed |
| US-20080214552-A1 | Substituted Pyridazinecarboxamides and Derivatives Thereof | BAYER CROPSCIENCE AG (DE) | 2008-09-04 | — | — | US | disclosed |
| US-20080194549-A1 | Organic Compounds | NOVARTIS AG (CH) | 2008-08-14 | — | — | US | disclosed |
| CN-101238107-A | Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation | GLENMARK PHARMACEUTICALS SA (CH) | 2008-08-06 | — | — | CN | disclosed |
| US-7390803-B2 | Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity | MERCK & CO., INC. (US) | 2008-06-24 | — | — | US | disclosed |
| US-20080146554-A1 | Substituted Cycloalkyl Derivatives, Process for the Manufacture thereof and Use thereof as Medicament | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-06-19 | — | — | US | disclosed |
| EP-1910272-A1 | RENIN INHIBITORS | Merck Frosst Canada Ltd. (CA) | 2008-04-16 | — | — | EP | disclosed |
| CN-101146530-A | 3, 4-substituted pyrrolidine derivatives for the treatment of hypertension | NOVARTIS AG (CH) | 2008-03-19 | — | — | CN | disclosed |
| EP-1399423-B9 | ANTHRANILIC ACID AMIDES WITH A HETEROARYLSULFONYL SIDE CHAIN, METHOD FOR THE PRODUCTION THEREOF, USE THEREOF AS A MEDICAMENT OR DIAGNOSTIC AGENT AND PHARMACEUTICAL PREPARATIONS CONTAINING SAID COMPOUNDS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2008-02-27 | — | — | EP | disclosed |
| EP-1863477-A1 | 3,4-SUBSTITUTED PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF HYPERTENSION | Novartis AG (CH) | 2007-12-12 | — | — | EP | disclosed |
| US-20070281919-A1 | Aminothiazole Derivatives And Their Use As CRF Receptor Ligands | SANOFI-AVENTIS (FR) | 2007-12-06 | — | — | US | disclosed |
| EP-1399423-B1 | ANTHRANILIC ACID AMIDES WITH A HETEROARYLSULFONYL SIDE CHAIN, METHOD FOR THE PRODUCTION THEREOF, USE THEREOF AS A MEDICAMENT OR DIAGNOSTIC AGENT AND PHARMACEUTICAL PREPARATIONS CONTAINING SAID COMPOUNDS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2007-11-14 | — | — | EP | disclosed |
| US-20070244156-A1 | SULFONYLAMINO-ACETIC ACID DERIVATIVES | ACTELION PHARMACEUTICALS LTD. (CH) | 2007-10-18 | — | — | US | disclosed |
| US-7279578-B2 | Sulfonylamino-acetic acid derivatives | ACTELION PHARMACEUTICALS LTD. (CH) | 2007-10-09 | — | — | US | disclosed |
| CN-1332942-C | Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists | ACTELION PHARMACEUTICALS LTD (CH) | 2007-08-22 | — | — | CN | disclosed |
| CN-1976585-A | Substituted pyridazine carboxamides and derivatives thereof | BAYER CROPSCIENCE AG (DE) | 2007-06-06 | — | — | CN | disclosed |
| EP-1763303-A1 | SUBSTITUTED PYRIDAZINE CARBOXAMIDES AND DERIVATIVES THEREOF | Bayer CropScience Aktiengesellschaft (DE) | 2007-03-21 | — | — | EP | disclosed |
| WO-2007009250-A1 | RENIN INHIBITORS | MERCK FROSST CANADA LTD. (CA) | 2007-01-25 | — | — | WO | disclosed |
| WO-2007009250-A1 | RENIN INHIBITORS | MERCK FROSST CANADA LTD. (CA) | 2007-01-25 | — | — | WO | disclosed |
| EP-1558243-A4 | TETRAHYDROPYRANYL CYCLOPENTYL BENZYLAMIDE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | MERCK & CO INC (US) | 2006-11-02 | — | — | EP | disclosed |
| EP-1707206-A1 | Piperazine derivates for the inhibition of beta-secretase, cathepsin D, plasmepsin ll and HIV protease and for the treatment of malaria, Alzeheimer and AIDS | Speedel Experimenta AG (CH) | 2006-10-04 | — | — | EP | disclosed |
| WO-2006100036-A1 | 3, 4-SUBSTITUTED PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF HYPERTENSION | NOVARTIS AG (CH) | 2006-09-28 | — | — | WO | disclosed |
| US-20060160794-A1 | Tachykinin receptor antagonists | ELI LILLY AND COMPANY | 2006-07-20 | — | — | US | disclosed |
| US-20060161004-A1 | Novel compounds | GLAXOSMITHKLINE SPA | 2006-07-20 | — | — | US | disclosed |
| US-20060116421-A1 | Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity | MERCK SHARP & DOHME CORP. | 2006-06-01 | — | — | US | disclosed |
| US-7030120-B2 | Nitrogen-containing heterocyclic compounds and benzamide compounds and drugs containing the same | MEIJI SEIKA KAISHA, LTD. (JP) | 2006-04-18 | — | — | US | disclosed |
| CN-1247544-C | Anthranilic acid amides with heteroarylsulfonyl side chains and their use as antiarrhythmic active substances | SANNOFFE AVENTIS DEUTSCHLAND G (DE) | 2006-03-29 | — | — | CN | disclosed |
| WO-2006021399-A2 | AZABICYCLONONENE DERIVATIVES AS RENIN INHIBITORS | ACTELION PHARMACEUTICALS LTD (CH) | 2006-03-02 | — | — | WO | disclosed |
| US-20060014783-A1 | Sulfonylamino-acetic acid derivatives | ACTELION PHARMACEUTICALS, LTD. (CH) | 2006-01-19 | — | — | US | disclosed |
| WO-2006000333-A1 | SUBSTITUTED PYRIDAZINE CARBOXAMIDES AND DERIVATIVES THEREOF | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2006-01-05 | — | — | WO | disclosed |
| CN-1703397-A | Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists | ACTELION PHARMACEUTICALS LTD (CH) | 2005-11-30 | — | — | CN | disclosed |
| US-20050261286-A1 | Substituted cycloalkyl derivatives, process for the manufacture thereof and use thereof as medicament | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-11-24 | — | — | US | disclosed |
| US-20050176700-A1 | 7-aryl-3,9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension,cardiovascular or renal diseases | ACTELION PHARMACEUTICALS LTD. (CH) | 2005-08-11 | — | — | US | disclosed |
| EP-1558243-A2 | TETRAHYDROPYRANYL CYCLOPENTYL BENZYLAMIDE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | Merck & Co., Inc. (US) | 2005-08-03 | — | — | EP | disclosed |
| CN-1649870-A | 7-aryl-3,9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases | ACTELION PHARMACEUTICALS LTD (CH) | 2005-08-03 | — | — | CN | disclosed |
| EP-1554239-A2 | SULFONYLAMINO-ACETIC ACID DERIVATIVES AND THEIR USE AS OREXIN RECEPTOR ANTAGONISTS | Actelion Pharmaceuticals Ltd. (CH) | 2005-07-20 | — | — | EP | disclosed |
| US-20050130228-A1 | Dosing form for a polymer support, use of said dosing form in organic chemical synthesis and method for production of said dosing form | H. LUNDBECK A/S (DK) | 2005-06-16 | — | — | US | disclosed |
| WO-2005037803-A1 | ORGANIC COMPOUNDS | SPEEDEL EXPERIMENTA AG (CH) | 2005-04-28 | — | — | WO | disclosed |
| US-20050070574-A1 | Novel compounds | GLAXOSMITHKLINE SPA AND LABORATOIRE | 2005-03-31 | — | — | US | disclosed |
| EP-1501830-A1 | 7-ARYL-3,9-DIAZABICYCLO[3.3.1]NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES | Actelion Pharmaceuticals Ltd. (CH) | 2005-02-02 | — | — | EP | disclosed |
| WO-2004105762-A1 | MEDICAL USE OF DIAZABICYCLONONENE DERIVATIVES AS INHIBITORS OF PARASITE ASPARTIC PROTEASES | ACTELION PHARMACEUTICALS LTD (CH) | 2004-12-09 | — | — | WO | disclosed |
| US-20040224959-A1 | Nitrogen-containing heterocyclic compounds and benzamide compounds and drugs containing the same | OHKURA NAOTO (JP) | 2004-11-11 | — | — | US | disclosed |
| CN-1529695-A | Anthranilic acid amides with heteroarylsulfonyl side chains, method for the production thereof, use thereof as medicaments or diagnostic agents, and pharmaceutical preparations containing said compounds | ������ҽҩ�¹�����˾ | 2004-09-15 | — | — | CN | disclosed |
| US-6777414-B1 | INHIBITORS OF TRIGLYCERIDE BIOSYNTHESIS AND SECRETION OF APOLIPOPROTEIN B-CONTAINING LIPOPROTEINS; ARTERIOSCLEROTIC DISEASES; HYPERLIPIDEMIA | MEIJI SEIKA KAISHA, LTD. (JP) | 2004-08-17 | — | — | US | disclosed |
| US-20040102633-A1 | Novel compounds | GLAXOSMITHKLINE S.P.A. (IT) | 2004-05-27 | — | — | US | disclosed |
| WO-2004041161-A2 | TETRAHYDROPYRANYL CYCLOPENTYL BENZYLAMIDE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | MERCK & CO., INC. (US) | 2004-05-21 | — | — | WO | disclosed |
| WO-2004033418-A2 | SULFONYLAMINO-ACETIC DERIVATIVES AND THEIR USE AS OREXIN RECEPTOR ANTAGONISTS | ACTELION PHARMACEUTICALS LTD. (CH) | 2004-04-22 | — | — | WO | disclosed |
| EP-1200419-B1 | AMINOTHIAZOLE DERIVATIVES AND THEIR USE AS CRF RECEPTOR LIGANDS | SANOFI SYNTHELABO (FR) | 2004-04-14 | — | — | EP | disclosed |
| EP-1399423-A2 | ANTHRANILIC ACID AMIDES WITH A HETEROARYLSULFONYL SIDE CHAIN, METHOD FOR THE PRODUCTION THEREOF, USE THEREOF AS A MEDICAMENT OR DIAGNOSTIC AGENT AND PHARMACEUTICAL PREPARATIONS CONTAINING SAID COMPOUNDS | Aventis Pharma Deutschland GmbH (DE) | 2004-03-24 | — | — | EP | disclosed |
| EP-1385820-A1 | ANTHRANILIC ACID AMIDES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS ANTIARRHYTHMIA AGENTS, AND PHARMACEUTICAL PREPARATIONS THEREOF | Sanofi-Aventis Deutschland GmbH (DE) | 2004-02-04 | — | — | EP | disclosed |
| WO-2003093267-A1 | 7-ARYL-3,9-DIAZABICYCLO(3.3.1)NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES | ACTELION PHARMACEUTICALS LTD (CH) | 2003-11-13 | — | — | WO | disclosed |
| EP-1339691-A1 | NOVEL COMPOUNDS | GlaxoSmithKline S.p.A. (IT) | 2003-09-03 | — | — | EP | disclosed |
| US-20030138847-A1 | Dosing form for a polymer support, use of said dosing form in organic chemical synthesis and method for production of said dosing form | H. LUNDBECK A/S (DK) | 2003-07-24 | — | — | US | disclosed |
| CN-1427743-A | Dosage forms of polymeric carriers, their use in organic chemical synthesis and process for producing said dosage forms | LONDBERK AS H (DK) | 2003-07-02 | — | — | CN | disclosed |
| US-6586456-B1 | Corticotropin releasing factor (CRF) antagonists such as (4-(2-chloro-4-methoxy-5-methylphenyl)-5-methylthiazol-2-yl)(( (1-(3-fluoro-4-methylphenyl)-2-methoxyethyl))prop-2-ynylamine, prepared by alkylation with propagyl bromide | SANOFI-SYNTHELABO (FR) | 2003-07-01 | — | — | US | disclosed |
| WO-2002100825-A2 | ANTHRANILIC ACID AMIDES WITH A HETEROARYLSULFONYL SIDE CHAIN, AND USE THEREOF AS ANTIARRHYTHMIC ACTIVE SUBSTANCES | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-12-19 | — | — | WO | disclosed |
| WO-2002088073-A1 | ANTHRANILIC ACID AMIDES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS ANTIARRHYTHMIA AGENTS, AND PHARMACEUTICAL PREPARATIONS THEREOF | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-11-07 | — | — | WO | disclosed |
| WO-2002044154-A1 | NOVEL COMPOUNDS | GLAXOSMITHKLINE SPA (IT) | 2002-06-06 | — | — | WO | disclosed |
| EP-1200419-A1 | AMINOTHIAZOLE DERIVATIVES AND THEIR USE AS CRF RECEPTOR LIGANDS | SANOFI-SYNTHELABO (FR) | 2002-05-02 | — | — | EP | disclosed |
| EP-1180514-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND BENAMIDE COMPOUNDS AND DRUGS CONTAINING THE SAME | MEIJI SEIKA KAISHA LTD. (JP) | 2002-02-20 | — | — | EP | disclosed |
| WO-2001068616-A1 | SUBSTITUTED 1-ARYL-CYCLOPROPYLMETHYLAMINO-1,3,5-TRIAZINES | BAYER AKTIENGESELLSCHAFT (DE) | 2001-09-20 | — | — | WO | disclosed |
| WO-2001005776-A1 | AMINOTHIAZOLE DERIVATIVES AND THEIR USE AS CRF RECEPTOR LIGANDS | SANOFI-SYNTHELABO (FR) | 2001-01-25 | — | — | WO | disclosed |
| CN-1058964-C | Branched-amino-sbustituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them | SANOFI SA (FR) | 2000-11-29 | — | — | CN | disclosed |
| US-6143917-A | FROM A DIARYL CARBONATE AND AN AMINE COMPOUND HAVING AT LEAST ONE HYDROGEN ATOM LOCATED AT AN N-POSITION UNDER MODERATE CONDITIONS AT A HIGH REACTION RATE WITH A HIGH SELECTIVITY AND WITH A HIGH YIELD | UBE INDUSTRIES, LTD. (JP) | 2000-11-07 | — | — | US | disclosed |
| US-5998427-A | REDUCTASE INHIBITOR | GLAXO WELLCOME INC. (US) | 1999-12-07 | — | — | US | disclosed |
| EP-0783001-B1 | Androstenones | GLAXO WELLCOME INC (US) | 1999-11-17 | — | — | EP | disclosed |
| US-5977126-A | ANTIANGROGENS, ENZYME INHBITORS | GLAXO WELLCOME INC. (US) | 1999-11-02 | — | — | US | disclosed |
| EP-0902014-A1 | PROCESS FOR PRODUCING ARYL CARBAMATES | UBE INDUSTRIES LIMITED (JP) | 1999-03-17 | — | — | EP | disclosed |
| CN-1041939-C | Androstenones | GLAXO INC (US) | 1999-02-03 | — | — | CN | disclosed |
| US-5817818-A | THERAPY OF ANDROGEN RESPONSIVE DISEASES | GLAXO WELLCOME INC. (US) | 1998-10-06 | — | — | US | disclosed |
| EP-0659747-B1 | Branched aminothiazole derivatives process for their preparation and pharmaceutical compositions containing them | SANOFI SA (FR) | 1998-04-01 | — | — | EP | disclosed |
| EP-0576350-B1 | Branched alkylamino thiazole derivatives, process for their preparation and pharmaceutical compositions containing them | SANOFI SA (FR) | 1997-10-29 | — | — | EP | disclosed |
| EP-0357217-B1 | Ethylene alpha-olefin copolymer substituted amino phenol mannich base lubricant dispersant additives | EXXON CHEMICAL PATENTS INC (US) | 1997-09-10 | — | — | EP | disclosed |
| CN-1035552-C | branched alkylamino derivatives of thiazoles, process for their preparation and pharmaceutical compositions containing them | SANOFI ELF (FR) | 1997-08-06 | — | — | CN | disclosed |
| EP-0783001-A1 | Androstenones | GLAXO WELLCOME INC. (US) | 1997-07-09 | — | — | EP | disclosed |
| EP-0779296-A2 | D-alpha-aminoalkanoyl-(S)-N-alpha-alkylbenzyl amides useful as intermediates for artificial sweeteners | THE COCA-COLA COMPANY (US) | 1997-06-18 | — | — | EP | disclosed |
| CN-1134155-A | Androstenones | GLAXO INC (US) | 1996-10-23 | — | — | CN | disclosed |
| EP-0736037-A1 | NOVEL INTERMEDIATES FOR THE SYNTHESIS OF L-ASPARTYL-D-$g(a)-AMINOALKANOYL-(S)-N-$g(a)-ALKYLBENZYL AMIDES USEFUL AS ARTIFICIAL SWEETENERS | THE COCA-COLA COMPANY (US) | 1996-10-09 | — | — | EP | disclosed |
| EP-0719277-A1 | ANDROSTENONES | GLAXO WELLCOME INC. (US) | 1996-07-03 | — | — | EP | disclosed |
| WO-1995017418-A2 | NOVEL INTERMEDIATES FOR THE SYNTHESIS OF L-ASPARTYL-D-α-AMINOALKANOYL-(S)-N-α-ALKYLBENZYL AMIDES USEFUL AS ARTIFICIAL SWEETENERS | THE COCA-COLA COMPANY (US) | 1995-06-29 | — | — | WO | disclosed |
| EP-0659747-A1 | Branched aminothiazole derivatives process for their preparation and pharmaceutical compositions containing them | SANOFI (FR) | 1995-06-28 | — | — | EP | disclosed |
| WO-1995007926-A1 | ANDROSTENONES | GLAXO WELLCOME INC. (US) | 1995-03-23 | — | — | WO | disclosed |
| CN-1097949-A | As the L-aspartyl-D-alpha-amino group alkyloyl of artificial sweetner-(S)-N-alpha-alkyl benzyl acid amides | COCA COLA CO (US) | 1995-02-01 | — | — | CN | disclosed |
| CN-1085898-A | branched alkylamino derivatives of thiazoles, process for their preparation and pharmaceutical compositions containing them | SANOFI ELF (FR) | 1994-04-27 | — | — | CN | disclosed |
| US-5286509-A | L-aspartyl-D-α-aminoalkanoyl-(S)-N-alpha-alkylbenzyl amides useful as artificial sweeteners | THE COCA-COLA COMPANY (US) | 1994-02-15 | — | — | US | disclosed |
| EP-0576350-A1 | Branched alkylamino thiozole derivatives, process for their preparation and pharmaceutical compositions containing them | SANOFI (FR) | 1993-12-29 | — | — | EP | disclosed |
| US-4803268-A | HERBICIDES, PLANT GROWTH REGULATORS | CIBA-GEIGY CORPORATION (US) | 1989-02-07 | — | — | US | disclosed |
| US-4579684-A | Process for the manufacture of enol derivatives | CIBA-GEIGY CORPORATION (US) | 1986-04-01 | — | — | US | disclosed |
| US-4550162-A | Process for the manufacture of enol derivatives | CIBA-GEIGY CORPORATION (US) | 1985-10-29 | — | — | US | disclosed |
| US-4434287-A | Cephalosporin derivatives | CIBA-GEIGY CORPORATION (US) | 1984-02-28 | — | — | US | disclosed |
| US-4319027-A | Process for the manufacture of ceohem enol derivatives | CIBA-GEIGY CORPORATION (US) | 1982-03-09 | — | — | US | disclosed |
| US-4313945-A | 7-Thiazolyl-acetamido-cephem derivatives with terminal aminocarboxylic acid grouping | CIBA-GEIGY CORPORATION (US) | 1982-02-02 | — | — | US | disclosed |
| US-4293462-A | Process for the manufacture of enol derivatives, and intermediates | CIBA-GEIGY CORPORATION (US) | 1981-10-06 | — | — | US | disclosed |
| EP-0016296-A1 | Cephalosporin derivatives, process for their preparation, compositions containing them, and intermediates and their preparation | CIBA-GEIGY AG (CH) | 1980-10-01 | — | — | EP | disclosed |
| US-4110533-A | PROCESS FOR THE MANUFACTURE OF ENOL DERIVATIVES | CIBA-GEIGY CORPORATION (US) | 1978-08-29 | — | — | US | disclosed |
| US-4110533-A | PROCESS FOR THE MANUFACTURE OF ENOL DERIVATIVES | CIBA-GEIGY CORPORATION (US) | 1978-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (50 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180153169-A1 | METHOD FOR TREATING COFFEE RUST, CITRUS BLACK SPOT, CITRUS SCAB AND BANANA BLACK SIGATOKA DISEASES | AMY1A, MANBA, CHIA | GRIN2B 3664/4885MEN1 3454/4885KMT2A 3225/4885 |
| US-11254681-B2 | Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases | PPARD, PPARG, RORC | GRIN2B 2066/4885MEN1 3331/4885KMT2A 2377/4885 |
| US-20140371214-A1 | INHIBITORS OF HISTONE DEMETHYLASES | KDM1B, KDM1A, KDM3A | GRIN2B 3056/4885MEN1 3081/4885KMT2A 41/4885 |
| US-20080214552-A1 | Substituted Pyridazinecarboxamides and Derivatives Thereof | PFAS, CYP4Z1, CYP4F12 | GRIN2B 1429/4885MEN1 2515/4885KMT2A 1713/4885 |
| US-20060014783-A1 | Sulfonylamino-acetic acid derivatives | HCRTR2, HCRTR1, GIPR | GRIN2B 417/4885MEN1 1377/4885KMT2A 800/4885 |
| US-20120046293-A1 | RENIN INHIBITORS | REN, ACE, AGTR1 | GRIN2B 3003/4885MEN1 3395/4885KMT2A 4587/4885 |
| US-20050070574-A1 | Novel compounds | NR1H3, NR1H2, CNR1 | GRIN2B 629/4885MEN1 3329/4885KMT2A 3392/4885 |
| US-20150025075-A1 | HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS | P2RX7, P2RX1, P2RX3 | GRIN2B 310/4885MEN1 3993/4885KMT2A 2894/4885 |
| US-20070281919-A1 | Aminothiazole Derivatives And Their Use As CRF Receptor Ligands | CRH, CRHR1, CRHR2 | GRIN2B 89/4885MEN1 2126/4885KMT2A 2839/4885 |
| US-20080146554-A1 | Substituted Cycloalkyl Derivatives, Process for the Manufacture thereof and Use thereof as Medicament | CHRM1, CHRM2, CHRM3 | GRIN2B 2795/4885MEN1 4355/4885KMT2A 3785/4885 |
| US-20060116421-A1 | Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity | CCR2, CCR1, CCR9 | GRIN2B 1469/4885MEN1 3827/4885KMT2A 2967/4885 |
| US-20140005167-A1 | KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH SAME | MAP3K7, MAP3K1, MAP3K20 | GRIN2B 1697/4885MEN1 1067/4885KMT2A 579/4885 |
| US-20150250176-A1 | METHOD FOR ENHANCING TOLERANCE TO ABIOTIC STRESS IN PLANTS USING CARBOXAMIDE OR THIOCARBOXAMIDE DERIVATIVES | TST, NAAA, AADAC | GRIN2B 2952/4885MEN1 4741/4885KMT2A 694/4885 |
| US-20190159452-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING A (THIO)CARBOXAMIDE DERIVATIVE AND A FUNGICIDAL COMPOUND | AADAC, TUBA3C, NAT1 | GRIN2B 961/4885MEN1 3631/4885KMT2A 526/4885 |
| US-20060160794-A1 | Tachykinin receptor antagonists | TACR1, TACR2, PROKR1 | GRIN2B 536/4885MEN1 824/4885KMT2A 1262/4885 |
| US-20040224959-A1 | Nitrogen-containing heterocyclic compounds and benzamide compounds and drugs containing the same | APOB, NCEH1, LIPC | GRIN2B 2626/4885MEN1 4072/4885KMT2A 2580/4885 |
| US-20060161004-A1 | Novel compounds | SLC10A1, ABCB11, AQP1 | GRIN2B 3152/4885MEN1 318/4885KMT2A 4394/4885 |
| US-20210054007-A1 | RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | TACR1, TACR2, GPBAR1 | GRIN2B 614/4885MEN1 2752/4885KMT2A 3517/4885 |
| US-20100324091-A1 | Pyrazolone Derivative | SERPINE1, SERPINC1, TFPI | GRIN2B 4254/4885MEN1 2985/4885KMT2A 4670/4885 |
| US-20150065477-A1 | CARBOXAMIDE COMPOUNDS AND THEIR USE AS CALPAIN INHIBITORS V | CAPN1, CAPN2, CAPNS1 | GRIN2B 1857/4885MEN1 4257/4885KMT2A 2270/4885 |
| US-20050176700-A1 | 7-aryl-3,9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension,cardiovascular or renal diseases | REN, AGTR1, ACE | GRIN2B 3006/4885MEN1 2389/4885KMT2A 4221/4885 |
| US-20170347651-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING A (THIO)CARBOXAMIDE DERIVATIVE AND FUNGICIDAL COMPOUND(S) | AADAC, PFAS, TPMT | GRIN2B 3148/4885MEN1 4024/4885KMT2A 1058/4885 |
| US-20200045965-A1 | METHOD FOR THE CONTROL OF PLANT BACTERIAL DISEASES USING CARBOXAMIDE DERIVATIVES | BROX, NAAA, SIRT5 | GRIN2B 1411/4885MEN1 3850/4885KMT2A 665/4885 |
| US-20110190278-A1 | BICYCLIC HETEROCYCLIC DERIVATIVE | REN, AGTR1, AGTR2 | GRIN2B 897/4885MEN1 1068/4885KMT2A 1812/4885 |
| US-20150245610-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING CARBOXAMIDE DERIVATIVES | AADAC, PFAS, CBR3 | GRIN2B 2281/4885MEN1 4245/4885KMT2A 720/4885 |
| US-20130217910-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED N-(BENZYL)CYCLOPROPANAMINES BY IMINE HYDROGENATION | DHPS, PNMT, INMT | GRIN2B 3131/4885MEN1 3095/4885KMT2A 2375/4885 |
| US-20200392140-A1 | OPTIONALLY FUSED HETEROCYCLYL- SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES | PPARD, PPARG, RORC | GRIN2B 2066/4885MEN1 3331/4885KMT2A 2377/4885 |
| US-20050261286-A1 | Substituted cycloalkyl derivatives, process for the manufacture thereof and use thereof as medicament | CHRM1, CHRM2, CHRM3 | GRIN2B 2795/4885MEN1 4355/4885KMT2A 3785/4885 |
| US-10945433-B2 | Method for treating coffee rust, citrus black spot, citrus scab and banana black sigatoka diseases | AMY1A, MANBA, CHIA | GRIN2B 3664/4885MEN1 3454/4885KMT2A 3225/4885 |
| US-20080194549-A1 | Organic Compounds | REN, ACE, OTC | GRIN2B 3817/4885MEN1 2785/4885KMT2A 3912/4885 |
| US-20090281103-A1 | Renin Inhibitors | REN, ACE, AGT | GRIN2B 3161/4885MEN1 3226/4885KMT2A 4576/4885 |
| US-20150259294-A1 | METHOD OF PLANT GROWTH PROMOTION USING CARBOXAMIDE DERIVATIVES | GFM1, MKI67, CPS1 | GRIN2B 920/4885MEN1 4484/4885KMT2A 300/4885 |
| US-20170342074-A1 | OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES | PPARD, PPARG, RORC | GRIN2B 2066/4885MEN1 3331/4885KMT2A 2377/4885 |
| US-10683293-B2 | Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases | PPARD, PPARG, RORC | GRIN2B 2066/4885MEN1 3331/4885KMT2A 2377/4885 |
| US-20160237037-A1 | INHIBITORS OF HISTONE DEMETHYLASES | KDM1B, KDM1A, KDM3A | GRIN2B 3056/4885MEN1 3081/4885KMT2A 41/4885 |
| US-20250114460-A1 | NOVEL PLK1 DEGRADATION INDUCING COMPOUND | PLK1, BUB1B, BUB1 | GRIN2B 3407/4885MEN1 3403/4885KMT2A 1840/4885 |
| US-20120295905-A1 | NEW ANTI-MALARIAL AGENTS | QDPR, DHFR, ITPA | GRIN2B 2992/4885MEN1 3482/4885KMT2A 1045/4885 |
| US-20080312242-A1 | 7-ARYL-3, 9-DIAZABICYCLO(3.3.1)NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES | REN, AGTR1, ACE | GRIN2B 3006/4885MEN1 2389/4885KMT2A 4221/4885 |
| US-10945432-B2 | Active compound combinations comprising a (thio)carboxamide derivative and a fungicidal compound | AADAC, TPMT, PFAS | GRIN2B 3384/4885MEN1 4088/4885KMT2A 1170/4885 |
| US-20120122773-A1 | N-SUBSTITUTED-CYCLIC AMINO DERIVATIVE | REN, AGTR1, AGTR2 | GRIN2B 480/4885MEN1 1004/4885KMT2A 1646/4885 |
| US-20160009655-A1 | METHOD FOR PRODUCING CARBOXAMIDES | CBR3, NQO2, CPS1 | GRIN2B 334/4885MEN1 2087/4885KMT2A 204/4885 |
| US-20040102633-A1 | Novel compounds | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CBR1, NR1H3 | GRIN2B 1432/4885MEN1 3121/4885KMT2A 4037/4885 |
| US-20170114029-A1 | TREATMENT OF CHAGAS DISEASE | CXCR4, CBR1, CHRM1 | GRIN2B 2881/4885MEN1 2697/4885KMT2A 879/4885 |
| US-20150264927-A1 | METHOD FOR TREATING PLANTS AGAINST FUNGI RESISTANT TO FUNGICIDES USING CARBOXAMIDE OR THIOCARBOXAMIDE DERIVATIVES | SDHA, TPI1, CBR3 | GRIN2B 1713/4885MEN1 2952/4885KMT2A 338/4885 |
| US-10349658-B2 | Method for treating coffee rust, citrus black spot, citrus scab and banana black sigatoka diseases | AMY1A, MANBA, CHIA | GRIN2B 3664/4885MEN1 3454/4885KMT2A 3225/4885 |
| US-20190281826-A1 | METHOD FOR TREATING COFFEE RUST, CITRUS BLACK SPOT, CITRUS SCAB AND BANANA BLACK SIGATOKA DISEASES | AMY1A, MANBA, CHIA | GRIN2B 3723/4885MEN1 3601/4885KMT2A 3242/4885 |
| US-20150264928-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING CARBOXAMIDE DERIVATIVES AND A BIOLOGICAL CONTROL AGENT | CTRL, BROX, AADAC | GRIN2B 3178/4885MEN1 4174/4885KMT2A 625/4885 |
| US-20100056497-A1 | AMIDE DERIVATIVE | REN, AGTR1, AGTR2 | GRIN2B 768/4885MEN1 825/4885KMT2A 921/4885 |
| US-20070244156-A1 | SULFONYLAMINO-ACETIC ACID DERIVATIVES | HCRTR2, HCRTR1, GIPR | GRIN2B 417/4885MEN1 1377/4885KMT2A 800/4885 |
| US-20150094492-A1 | PROCESS FOR PREPARING N-(5-CHLORO-2-ISOPROPYLBENZYL)CYCLOPROPANAMINE | PNMT, NT5C, CPNE4 | GRIN2B 1310/4885MEN1 2044/4885KMT2A 1910/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.